REVIEW OF INTERLEUKIN-2 ALONE AND INTERLEUKIN-2 LAK CLINICAL-TRIALS IN METASTATIC MALIGNANT-MELANOMA

被引：19

作者：

SZNOL, M

DUTCHER, JP

ATKINS, MB

RAYNER, ARA

MARGOLIN, KA

GAYNOR, ER

WEISS, GR

ARONSON, F

PARKINSON, DR

HAWKINS, MJ

机构：

[1] ALBERT EINSTEIN CANC CTR, NEW YORK, NY USA

[2] NEW ENGLAND MED CTR, BOSTON, MA 02111 USA

[3] UNIV CALIF SAN FRANCISCO, CANC RES INST, SAN FRANCISCO, CA 94143 USA

[4] UNIV TEXAS SAN ANTONIO, SAN ANTONIO, TX 78285 USA

[5] LOYOLA UNIV, MED CTR, MAYWOOD, IL 60153 USA

[6] CITY HOPE CANC RES CTR, DUARTE, CA USA

来源：

关键词：

D O I：

10.1016/0305-7372(89)90020-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：29 / 38

页数：10

共 51 条

[1] ANDERSON PM, 1988, CANCER IMMUNOL IMMUN, V27, P825
[2] BOLDT DH, 1988, CANCER RES, V48, P4409
[3] INVIVO ANTITUMOR-ACTIVITY OF COMBINATIONS OF INTERFERON-ALPHA AND INTERLEUKIN-2 IN A MURINE MODEL - CORRELATION OF EFFICACY WITH THE INDUCTION OF CYTOTOXIC-CELLS RESEMBLING NATURAL-KILLER-CELLS
BRUNDA, MJ
BELLANTONI, D
SULICH, V
[J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) : 365 - 371
[4] COHEN PJ, 1987, AM J PATHOL, V129, P208
[5] DEFRIES RU, 1988, J IMMUNOL, V140, P3686
[6] DUTCHER JP, 1987, P ASCO, V6, pA970
[7] EISENTHAL A, 1987, CANCER RES, V47, P2771
[8] CROSS LINKING OF ANTI-B16 MELANOMA MONOCLONAL-ANTIBODIES TO LYMPHOKINE ACTIVATED KILLER (LAK) CELLS - POSSIBLE ROLE IN THE THERAPY OF B-16 MELANOMA
EISENTHAL, A
ROSENBERG, SA
[J]. CLINICAL & EXPERIMENTAL METASTASIS, 1988, 6 (05) : 387 - 400
[9] EISENTHAL A, 1988, P ANN M AM ASS CANCE, V29, pA1703
[10] ETTINGHAUSEN SE, 1986, CANCER RES, V46, P2784